UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines

Journal of neurosurgery, 2005-07, Vol.103 (1), p.156-164

2005

Volltextzugriff (PDF)

Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9547-9554

2005

Volltextzugriff (PDF)

T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.61-70

2012

Volltextzugriff (PDF)

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination

Cellular immunology, 2006-09, Vol.243 (1), p.30-40

2006

Volltextzugriff (PDF)

Adoptive transfer of tumor-primed, in vitro–activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response

Blood, 2007-06, Vol.109 (11), p.4865-4872

2007

Volltextzugriff (PDF)

Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure

The Journal of immunology (1950), 2010-05, Vol.184 (10), p.5612-5618

2010

Volltextzugriff (PDF)

Direct Gene Transfer with DNA-Liposome Complexes in Melanoma: Expression, Biologic Activity, and Lack of Toxicity in Humans

Proceedings of the National Academy of Sciences - PNAS, 1993-12, Vol.90 (23), p.11307-11311

1993

Volltextzugriff (PDF)

T Cell Adoptive Immunotherapy of Newly Diagnosed Gliomas

Clinical cancer research, 2000-06, Vol.6 (6), p.2209-2218

2000

Volltextzugriff (PDF)

Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5245-5249

1999

Volltextzugriff (PDF)

Immunotherapy of Malignancy by in vivo Gene Transfer into Tumors

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (10), p.4645-4649

1993

Volltextzugriff (PDF)

Memory T Cells Originate from Adoptively Transferred Effectors and Reconstituting Host Cells after Sequential Lymphodepletion and Adoptive Immunotherapy

The Journal of immunology (1950), 2004-03, Vol.172 (6), p.3462-3468

2004

Volltextzugriff (PDF)

Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion

The Journal of immunology (1950), 2002-09, Vol.169 (6), p.3314

2002

Volltextzugriff (PDF)

Cross-Presentation of Tumor Antigens to Effector T Cells Is Sufficient to Mediate Effective Immunotherapy of Established Intracranial Tumors

The Journal of immunology (1950), 2000-10, Vol.165 (7), p.3656-3662

2000

Volltextzugriff (PDF)

Abstract 2478: A mAb with in vivo therapeutic activity against spontaneous breast tumors in FVB-neuN mice recognizes SLP-2

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2478-2478

2015

Volltextzugriff (PDF)

Abstract 2897: ERBB2 amplicon passenger genes: A novel class of breast cancer antigens

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2897-2897

2014

Volltextzugriff (PDF)

Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (19), p.4338-4342

1996

Volltextzugriff (PDF)

Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4702-4708

1996

Volltextzugriff (PDF)

T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.61

2012

Volltextzugriff (PDF)

Adoptive Immunotherapy of Advanced Tumors with CD62 L-Selectinlow Tumor-Sensitized T Lymphocytes Following Ex Vivo Hyperexpansion

The Journal of immunology (1950), 2002-09, Vol.169 (6), p.3314-3320

2002

Volltextzugriff (PDF)

Abstract 2853: Monoclonal antibodies derived in neuN mice following successful T cell therapy of spontaneous breast tumors are specific for tumor progenitor cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2853-2853

2013

Volltextzugriff (PDF)

Abstract 771: Therapy of spontaneous primary breast tumors in neu-N transgenic mice by adoptive transfer of vaccine-primed LN T cells also induces a humoral response

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.771-771

2011

Volltextzugriff (PDF)

T-cell adoptive immunotherapy of metastatic renal cell carcinoma

Urology (Ridgewood, N.J.), 1999-10, Vol.54 (4), p.617-623

1999

Volltextzugriff (PDF)

Gene transfer and vascular disease

Cardiovascular research, 1994-04, Vol.28 (4), p.445-455

1994

Volltextzugriff (PDF)

Considerations on clinical use of T cell immunotherapy for cancer

Archivum Immunologiae et Therapiae Experimentalis, 2003, Vol.51 (4), p.245-257

2003

Volltextzugriff (PDF)

Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells

Journal of translational medicine, 2004-11, Vol.2 (1), p.41-41

2004

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(69)
Reviews
(3)

Sprache

Englisch
(72)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines

Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells

T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination

Adoptive transfer of tumor-primed, in vitro–activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response

Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure

Direct Gene Transfer with DNA-Liposome Complexes in Melanoma: Expression, Biologic Activity, and Lack of Toxicity in Humans

T Cell Adoptive Immunotherapy of Newly Diagnosed Gliomas

Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy

Immunotherapy of Malignancy by in vivo Gene Transfer into Tumors

Memory T Cells Originate from Adoptively Transferred Effectors and Reconstituting Host Cells after Sequential Lymphodepletion and Adoptive Immunotherapy

Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion

Cross-Presentation of Tumor Antigens to Effector T Cells Is Sufficient to Mediate Effective Immunotherapy of Established Intracranial Tumors

Abstract 2478: A mAb with in vivo therapeutic activity against spontaneous breast tumors in FVB-neuN mice recognizes SLP-2

Abstract 2897: ERBB2 amplicon passenger genes: A novel class of breast cancer antigens

Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes

Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells

T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors

Adoptive Immunotherapy of Advanced Tumors with CD62 L-Selectinlow Tumor-Sensitized T Lymphocytes Following Ex Vivo Hyperexpansion

Abstract 2853: Monoclonal antibodies derived in neuN mice following successful T cell therapy of spontaneous breast tumors are specific for tumor progenitor cells

Abstract 771: Therapy of spontaneous primary breast tumors in neu-N transgenic mice by adoptive transfer of vaccine-primed LN T cells also induces a humoral response

T-cell adoptive immunotherapy of metastatic renal cell carcinoma

Gene transfer and vascular disease

Considerations on clinical use of T cell immunotherapy for cancer

Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells

Suchergebnisse filtern